$RETA REATA PHARMACEUTICALS INC Insider Trading
Get free email notifications about insider trading in REATA PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in REATA PHARMACEUTICALS INC. Insider overview, share value development, latest insider transactions and email notifications about new events in REATA PHARMACEUTICALS INC for free.
CIK Number: 0001358762
IRS Number: 113651945
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: RETA
Company Address: 5320 LEGACY DRIVE PLANO 75024
Phone number: 972-865-2219
Former name: Reata Discovery, Inc.
Former name: Signifix, Inc.
Market Capitalization: $515.29M
Prev close: $23.03
Average Daily Volume: 82,569
Days Low: $22.76
Year Low: $11.03
Year High: $41.60
REATA PHARMACEUTICALS INC Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 14 2021 | RETA | REATA PHARMACEUTIC ... | Ruff Shamim | Director | Option Exercise | A | 146.01 | 780 | 113,888 | 780 | |
Jun 14 2021 | RETA | REATA PHARMACEUTIC ... | Ruff Shamim | Director | Option Exercise | A | 146.01 | 5,000 | 730,050 | 5,000 | |
Jun 14 2021 | RETA | REATA PHARMACEUTIC ... | Nielsen Jack | Director | Option Exercise | A | 146.01 | 1,201 | 175,358 | 1,201 | |
Jun 14 2021 | RETA | REATA PHARMACEUTIC ... | Nielsen Jack | Director | Option Exercise | A | 146.01 | 5,000 | 730,050 | 5,000 | |
Apr 16 2021 | RETA | REATA PHARMACEUTIC ... | Ruff Shamim | Director | Option Exercise | A | 92.20 | 319 | 29,412 | 319 | |
Apr 16 2021 | RETA | REATA PHARMACEUTIC ... | Ruff Shamim | Director | Option Exercise | A | 92.20 | 10,000 | 922,000 | 10,000 | |
Apr 16 2021 | RETA | REATA PHARMACEUTIC ... | Ruff Shamim | Director | Option Exercise | A | 92.20 | 1,250 | 115,250 | 1,250 | |
Apr 16 2021 | RETA | REATA PHARMACEUTIC ... | Oliger Christy J. | Director | Option Exercise | A | 92.20 | 106 | 9,773 | 106 | |
Apr 16 2021 | RETA | REATA PHARMACEUTIC ... | Oliger Christy J. | Director | Option Exercise | A | 92.20 | 10,000 | 922,000 | 10,000 | |
Apr 16 2021 | RETA | REATA PHARMACEUTIC ... | Oliger Christy J. | Director | Option Exercise | A | 92.20 | 1,250 | 115,250 | 1,250 | |
Jan 06 2021 | RETA | REATA PHARMACEUTIC ... | WORTLEY MICHAEL D | Chief Legal Officer | Option Exercise | A | 121.29 | 16,500 | 2,001,285 | 16,500 | |
Jan 06 2021 | RETA | REATA PHARMACEUTIC ... | WORTLEY MICHAEL D | Chief Legal Officer | Option Exercise | A | 121.29 | 16,500 | 2,001,285 | 16,500 | |
Jan 06 2021 | RETA | REATA PHARMACEUTIC ... | Soni Manmeet Singh | COO and CFO | Option Exercise | A | 121.29 | 24,000 | 2,910,960 | 24,000 | |
Jan 06 2021 | RETA | REATA PHARMACEUTIC ... | Huff James Warren | Chief Executive Off ... | Option Exercise | A | 121.29 | 44,600 | 5,409,534 | 44,600 | |
Jan 06 2021 | RETA | REATA PHARMACEUTIC ... | Castellanos Elaine | VP, Chief Accountin ... | Option Exercise | A | 121.29 | 8,000 | 970,320 | 8,000 |